Home
Sarepta Therapeutics SRPT spent $250K on lobbying in Q3 2024 · Health Issues, Taxation and 1 more issue
Trade details
- Type
- Lobbying report
- Amount
- $250,000
- Quarter
- Q3 2024
- Client
- Sarepta Therapeutics
- Reported
- 24/10/21
Up 4.2% from last quarter
What else happened in Sarepta Therapeutics around then
Filed or reported within 30 days of the trade day · 24/08/31~24/10/30Sarepta Therapeutics's other lobbying reports
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$50K
$50K
Reported 07/20
for Q2
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$90K
$90K
Reported 07/20
for Q2
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$220K
$220K
Reported 07/20
for Q2
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$110K
$110K
Reported 04/20
for Q1
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$270K
$270K
Reported 04/20
for Q1